Thunder-fire moxibustion may reduce fatigue in colorectal cancer patients undergoing chemotherapy.

This randomized controlled trial evaluated 77 patients with Qi stagnation and blood stasis type colorectal cancer undergoing chemotherapy. The study compared conventional care plus thunder-fire moxibustion against conventional care alone.

The primary outcome assessed change in Revised Piper Fatigue Scale scores. Main results indicated a reduction in fatigue and improvement in sleep and quality of life. Secondary outcomes included sleep quality assessed by the Pittsburgh Sleep Quality Index, quality of life measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30, Traditional Chinese Medicine syndrome scores, routine blood indicators, and inflammatory factor levels. Thunder-fire moxibustion (TFM) was the specific intervention tested. However, effect sizes, absolute numbers, and p-values were not reported.

Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported. The follow-up duration was described only as during a follow-up period without specific timing. Limitations were not explicitly listed in the provided data.

The abstract uses the phrase 'may be an effective', indicating uncertainty about the efficacy. Clinicians should interpret these findings cautiously given the lack of statistical reporting, safety data, and follow-up details. Further research is needed to establish definitive clinical relevance. The evidence remains preliminary due to missing statistical metrics and safety data.